Goldman Sachs analyst Suhasini Varanasi upgraded Rentokil (RTO) Initial to Buy from Neutral with a price target of 590 GBp, up from 515 GBp. The organic growth inflection in North America, which started in Q3 of 2025, is sustainable with a potential to reach mid-single digit levels by 2027, the analyst tells investors in a research note. Goldman Sachs adds that it sees this improved growth allowing the company to gradually close the growth and valuation gap to peer Rollins (ROL) and drive a share price re-rating.
